ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trisolini, R.
Right arrow Articles by Poletti, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trisolini, R.
Right arrow Articles by Poletti, V.
Eur Respir J 2001; 18:243-245
Copyright ©ERS Journals Ltd 2001

Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy

R. Trisolini1,2, L. Lazzari Agli1, D. Tassinari3, D. Rondelli4, A. Cancellieri5, M. Patelli1, F. Falcone1 and V. Poletti1

1 Dept Thoracic Diseases and 5 Anatomic Pathology, Bellaria and Maggiore Hospitals, Bologna, Italy; 2 Dept Respiratory Diseases, S. Matteo University Hospital, Pavia, Italy; 3 Dept of Oncology, City Hospital, Rimini, Italy; 4 Institute of Hematology and Clinical Oncology "L & A Seragnoli", S. Orsola University Hospital, Bologna, Italy

CORRESPONDENCE: V. Poletti, Dept of Thoracic Diseases, Bellaria and Maggiore Hospital, Largo Nigrisoli 2, 40133, Bologna, Italy. Fax: 39 0516478727

Keywords: chemotherapy, diffuse alveolar damage, drug-induced toxicity, 5-fluorouracil, oxaliplatinum, rectum carcinoma

Received: January 22, 2001
Accepted February 19, 2001

Abstract

Diarrhoea, T-CD4+ lymphopenia and bilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with oxaliplatinum and 5-fluorouracil for unresectable rectum carcinoma. The findings from transbronchial lung biopsy and bronchoalveolar lavage (BAL) were consistent with an organizing diffuse alveolar damage pattern. Once extensive microbiological studies proved negative, corticosteroids were given and a complete remission of clinical and radiological abnormalities was achieved. It is concluded that the aforementioned pathological manifestations were due to chemotherapy and included a pulmonary adverse reaction, a feature never previously associated with oxaliplatinum and 5-fluorouracil regimens.




This article has been cited by other articles:


Home page
 ChestHome page
M. Garrido, A. O'Brien, S. Gonzalez, J. M. Clavero, and E. Orellana
Cryptogenic Organizing Pneumonitis During Oxaliplatin Chemotherapy for Colorectal Cancer: Case Report
Chest, December 1, 2007; 132(6): 1997 - 1999.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
N. Fuse, T. Doi, A. Ohtsu, S. Takeuchi, T. Kojima, K. Taku, M. Tahara, M. Muto, M. Asaka, and S. Yoshida
Feasibility of Oxaliplatin and Infusional Fluorouracil/Leucovorin (FOLFOX4) for Japanese Patients with Unresectable Metastatic Colorectal Cancer
Jpn. J. Clin. Oncol., June 1, 2007; 37(6): 434 - 439.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
I. Dimopoulou, A. Bamias, P. Lyberopoulos, and M. A. Dimopoulos
Pulmonary toxicity from novel antineoplastic agents
Ann. Onc., March 1, 2006; 17(3): 372 - 379.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the European Respiratory Society.